Gooch KE, Smith TRF, Salguero FJ, Fotheringham SA, et al. One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model. Vaccine 2021 Jun 23. pii: S0264-410X(21)00807.
PMID: 34253420